Quest Diagnostics has seen its Fair Value Estimate rise moderately from $191.56 to $197.25 per share, reflecting a more optimistic outlook among analysts. This upward revision is largely due to strong ...

The fireside chat and Q&A session will be webcast live during the conference on the company’s investor relations page, which ...

A mismatch between two common tests for kidney function may indicate a higher risk for kidney failure, heart disease, and ...

According to Mordor Intelligence, the global companion diagnostics market is valued at USD 8.70 billion in 2025 and is projected to surpass USD 15.62 billion by 2030, growing at a CAGR of 12.42% ...

At-home tests of the gut's microbiome are trending, but doctors say the technology is getting ahead of medical knowledge ...

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the ...

A regular medical examination can already feel daunting amid the uncertainty of what doctors will discover. Behind every scan ...

The firm said that growth in its immunodiagnostics business was offset by contraction in its molecular diagnostics, licensed technologies, and COVID-19 businesses.

The shift toward point-of-care and home-based testing, coupled with AI-integrated diagnostics, is transforming the market ...

The global clinical diagnostics industry is entering a new era of technological progress and healthcare transformation.

This article was reviewed by Darragh O’Carroll, MD. Pros, Cons & Benefits of At-Home Lab Testing You probably don’t have time ...

At-home gut microbiome tests are growing in popularity, marketed as tools to unlock insights into digestion, immunity and ...